BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 15494606)

  • 1. Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2.
    Widemann BC; Balis FM; Shalabi A; Boron M; O'Brien M; Cole DE; Jayaprakash N; Ivy P; Castle V; Muraszko K; Moertel CL; Trueworthy R; Hermann RC; Moussa A; Hinton S; Reaman G; Poplack D; Adamson PC
    J Natl Cancer Inst; 2004 Oct; 96(20):1557-9. PubMed ID: 15494606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re: Treatment of accidental intrathecal methotrexate overdose.
    Gosselin S; Isbister GK
    J Natl Cancer Inst; 2005 Apr; 97(8):609-10; author reply 610-1. PubMed ID: 15840887
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful treatment of intrathecal methotrexate overdose by using ventriculolumbar perfusion and intrathecal instillation of carboxypeptidase G2.
    O'Marcaigh AS; Johnson CM; Smithson WA; Patterson MC; Widemann BC; Adamson PC; McManus MJ
    Mayo Clin Proc; 1996 Feb; 71(2):161-5. PubMed ID: 8577190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rescue of experimental intrathecal methotrexate overdose with carboxypeptidase-G2.
    Adamson PC; Balis FM; McCully CL; Godwin KS; Bacher JD; Walsh TJ; Poplack DG
    J Clin Oncol; 1991 Apr; 9(4):670-4. PubMed ID: 2066764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma.
    Widemann BC; Balis FM; Kempf-Bielack B; Bielack S; Pratt CB; Ferrari S; Bacci G; Craft AW; Adamson PC
    Cancer; 2004 May; 100(10):2222-32. PubMed ID: 15139068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction.
    Widemann BC; Balis FM; Murphy RF; Sorensen JM; Montello MJ; O'Brien M; Adamson PC
    J Clin Oncol; 1997 May; 15(5):2125-34. PubMed ID: 9164227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed elimination of high-dose methotrexate and use of carboxypeptidase G2 in pediatric patients during treatment for acute lymphoblastic leukemia.
    Svahn T; Mellgren K; Harila-Saari A; Åsberg A; Kanerva J; Jónsson Ó; Vaitkeviciene G; Stamm Mikkelssen T; Schmiegelow K; Heldrup J
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 27966809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic drug monitoring of methotrexate in cerebrospinal fluid after systemic high-dose infusion in children: can the burden of intrathecal methotrexate be reduced?
    Niemann A; Mühlisch J; Frühwald MC; Gerss J; Hempel G; Boos J
    Ther Drug Monit; 2010 Aug; 32(4):467-75. PubMed ID: 20571463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Carboxypeptidase-G2 administration after high-dose methotrexate. Treatment and drug interactions].
    Cózar Olmo JA; Martínez Colmenero C; Peláez Pleguezuelos I; Leiva Gea I; López García AB; de la Cruz Moreno J
    An Pediatr (Barc); 2009 Sep; 71(3):230-4. PubMed ID: 19617010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carboxypeptidase-G2 rescue in a patient with high dose methotrexate-induced nephrotoxicity.
    Widemann BC; Hetherington ML; Murphy RF; Balis FM; Adamson PC
    Cancer; 1995 Aug; 76(3):521-6. PubMed ID: 8625136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of two cases on the same day of intrathecal methotrexate overdose using cerebrospinal fluid exchange and intrathecal instillation of carboxypeptidase-G2.
    Wormdal OM; Flægstad T; Stokland T
    Pediatr Hematol Oncol; 2018; 35(5-6):350-354. PubMed ID: 30672361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed recognition of intrathecal methotrexate overdose.
    Malbora B; Ozyurek E; Kocum AI; Ozbek N
    J Pediatr Hematol Oncol; 2009 May; 31(5):352-4. PubMed ID: 19415018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carboxypeptidase G2 rescue in patients with methotrexate intoxication and renal failure.
    Buchen S; Ngampolo D; Melton RG; Hasan C; Zoubek A; Henze G; Bode U; Fleischhack G
    Br J Cancer; 2005 Feb; 92(3):480-7. PubMed ID: 15668713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathecal methotrexate-induced acute cerebellar syndrome.
    Ferhanoglu B; Ongören S; Ar CM; Uzel B; Forta H; Necioglu D
    Ann Hematol; 2003 Apr; 82(4):241-3. PubMed ID: 12707728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful use of intrathecal carboxypeptidase G2 for intrathecal methotrexate overdose: a case study and review of the literature.
    Bradley AM; Buie LW; Kuykendal A; Voorhees PM
    Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):166-70. PubMed ID: 23084403
    [No Abstract]   [Full Text] [Related]  

  • 16. Intrathecal methotrexate-induced acute chorea.
    Necioğlu Orken D; Yldrmak Y; Kenangil G; Kandraloğlu N; Forta H; Celik M
    J Pediatr Hematol Oncol; 2009 Jan; 31(1):57-8. PubMed ID: 19125090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucarpidase (carboxypeptidase g2) intervention in adult and elderly cancer patients with renal dysfunction and delayed methotrexate elimination after high-dose methotrexate therapy.
    Schwartz S; Borner K; Müller K; Martus P; Fischer L; Korfel A; Auton T; Thiel E
    Oncologist; 2007 Nov; 12(11):1299-308. PubMed ID: 18055849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathecal methotrexate overdose.
    Lee AC; Wong KW; Fong KW; So KT
    Acta Paediatr; 1997 Apr; 86(4):434-7. PubMed ID: 9174236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelopathy due to intrathecal chemotherapy: magnetic resonance imaging findings.
    Counsel P; Khangure M
    Clin Radiol; 2007 Feb; 62(2):172-6. PubMed ID: 17207701
    [No Abstract]   [Full Text] [Related]  

  • 20. Methotrexate pharmacokinetics following administration of recombinant carboxypeptidase-G2 in rhesus monkeys.
    Adamson PC; Balis FM; McCully CL; Godwin KS; Poplack DG
    J Clin Oncol; 1992 Aug; 10(8):1359-64. PubMed ID: 1634927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.